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Abstract 
Patients with post-operative cardiogenic shock can 
be treated with very high insulin doses (HIET). A 
model-based HIET protocol should allow safe and 
effective treatment. This study shows that modeled 
plasma insulin clearance should be decreased 
during the first 10 hours of HIET then largely 
increased. This insulin clearance increase could 
result from both elimination via the urine and 
storage in the interstitial space. These findings 
should lead to new clinical protocols, as HIET 
should not be applied for more than 10 hours. 
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1 Introduction 
Insulin has beneficial effects on cardiac function at 
very high doses. Hyper-Insulinemia Euglycemia 
Therapy (HIET) uses these insulin effects to treat 
patients with post-operative cardiogenic shock. 
During HIET, insulin infusions can reach 1 U/kg/h 
and exogenous glucose is thus required to avoid 
hypoglycemia but must also be limited to avoid 
gluco-toxicity effects. Clinical application of HIET is 
currently empirical, the hypoglycemic risk is high 
and controlling high insulin dosing can be very 
difficult as patient metabolism and insulin sensitivity 
are variable during the therapy. Our work aims to 
develop a model-based protocol to optimize HIET 
interventions (exogenous insulin and dextrose 
dosing), enabling a safe and effective therapy.  
 
2 Method 
The model of the glucose-insulin system is adapted 
for HIET patients, especially the plasma insulin 
clearance [1]. Data from 5 patients treated with 
HIET in Liege University Hospital (Belgium) include 
insulin data (exogenous insulin input, measured 
plasma and urine insulin concentrations), glycemic 
data (blood glucose concentrations) and exogenous 
dextrose input data (enteral and parenteral nutrition, 
medication).  
3 Results 
Comparison of simulated and measured plasma 
insulin concentrations shows that modeled plasma 
insulin clearance should be reduced during the first 
10 hours of HIET, then increased significantly 
(Fig.1). To better capture observed patient behavior, 
we assumed that renal clearance initially saturates 
and de-saturates after 10 hours. At this point, a 
supplemental plasma insulin clearance term was 
introduced into the model. Figure 1 also shows a 
sudden increase in measured plasma insulin 
concentration (from 208.7 to 18880 mU/L) when 
HIET was stopped (t=66h), suggesting storage in 
some remote compartment. Insulin concentrations 
in urine were 262.5 mU/L (t=23h10), 444.8 mU/L 
(t=36h10) and 27.25 mU/L (t=84h10), suggesting 
that insulin is eliminated via the urine. 























Figure 1 – Measured (blue circles), simulated (black curve) 
and re-simulated (pink curve) plasma insulin concentration.  
 
4 Conclusion 
The adapted model better captures HIET patient 
behavior. After 10 hours of HIET, insulin clearance 
increases, normalizing plasma insulin concentration. 
We have shown that insulin is eliminated via the 
urine but possibly also stored, most likely in the 
interstitial space. More data should validate these 
findings but we can say that HIET becomes 
ineffective and should be stopped after 10 hours. 
Thus, HIET clinical protocols should be adapted.  
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